Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00945490
Recruitment Status : Completed
First Posted : July 24, 2009
Last Update Posted : March 10, 2017
Information provided by (Responsible Party):
Nymox Corporation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2014
Actual Study Completion Date : May 2014
Certification/Extension First Submitted : March 9, 2017